secwatch.observer — SEC 8-K summary
======================================

Issuer:     BAXTER INTERNATIONAL INC (BAX)
CIK:        0000010456
Form:       8-K
Filed at:   2025-02-03T23:59:59+00:00
Accession:  0001193125-25-018871
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baxter CEO Almeida retires; Brent Shafer appointed interim CEO; Heather Knight named COO
--------------------------------------------------------------------------------

- José Almeida retired as CEO/Chair effective Feb 3, 2025; will serve as Special Advisor through Oct 31, 2025.
- Brent Shafer (former Cerner CEO, Baxter director since 2022) appointed interim CEO and Chair; Board seeks permanent CEO.
- Heather Knight named EVP and COO; previously led Medical Products & Therapies segment; reports to interim CEO.
- Q4/FY2024 results expected in line with prior continuing ops guidance; earnings call scheduled for Feb 20, 2025.
- 2025 objectives: 4–5% operational sales growth and ~16.5% adjusted operating margin; tariffs impact not yet included.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10456/000119312525018871/0001193125-25-018871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10456/000119312525018871/d907276d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-018871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer